JP2024150466A5 - - Google Patents

Download PDF

Info

Publication number
JP2024150466A5
JP2024150466A5 JP2024103249A JP2024103249A JP2024150466A5 JP 2024150466 A5 JP2024150466 A5 JP 2024150466A5 JP 2024103249 A JP2024103249 A JP 2024103249A JP 2024103249 A JP2024103249 A JP 2024103249A JP 2024150466 A5 JP2024150466 A5 JP 2024150466A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024103249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024150466A (ja
JP7789850B2 (ja
Filing date
Publication date
Priority claimed from PCT/IB2021/054225 external-priority patent/WO2021234544A1/en
Application filed filed Critical
Publication of JP2024150466A publication Critical patent/JP2024150466A/ja
Publication of JP2024150466A5 publication Critical patent/JP2024150466A5/ja
Priority to JP2025244399A priority Critical patent/JP2026048795A/ja
Application granted granted Critical
Publication of JP7789850B2 publication Critical patent/JP7789850B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024103249A 2020-05-18 2024-06-26 Lnp023の結晶形態 Active JP7789850B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025244399A JP2026048795A (ja) 2020-05-18 2025-12-10 Lnp023の結晶形態

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202063026637P 2020-05-18 2020-05-18
US63/026,637 2020-05-18
US202063052699P 2020-07-16 2020-07-16
US63/052,699 2020-07-16
PCT/IB2021/054225 WO2021234544A1 (en) 2020-05-18 2021-05-17 Crystalline form of lnp023
JP2022557633A JP7592743B2 (ja) 2020-05-18 2021-05-17 Lnp023の結晶形態

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022557633A Division JP7592743B2 (ja) 2020-05-18 2021-05-17 Lnp023の結晶形態

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025244399A Division JP2026048795A (ja) 2020-05-18 2025-12-10 Lnp023の結晶形態

Publications (3)

Publication Number Publication Date
JP2024150466A JP2024150466A (ja) 2024-10-23
JP2024150466A5 true JP2024150466A5 (cg-RX-API-DMAC7.html) 2025-04-07
JP7789850B2 JP7789850B2 (ja) 2025-12-22

Family

ID=76076387

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022557633A Active JP7592743B2 (ja) 2020-05-18 2021-05-17 Lnp023の結晶形態
JP2024103249A Active JP7789850B2 (ja) 2020-05-18 2024-06-26 Lnp023の結晶形態
JP2025244399A Pending JP2026048795A (ja) 2020-05-18 2025-12-10 Lnp023の結晶形態

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022557633A Active JP7592743B2 (ja) 2020-05-18 2021-05-17 Lnp023の結晶形態

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025244399A Pending JP2026048795A (ja) 2020-05-18 2025-12-10 Lnp023の結晶形態

Country Status (10)

Country Link
US (3) US11603363B2 (cg-RX-API-DMAC7.html)
EP (1) EP4153580A1 (cg-RX-API-DMAC7.html)
JP (3) JP7592743B2 (cg-RX-API-DMAC7.html)
KR (2) KR20230009478A (cg-RX-API-DMAC7.html)
CN (4) CN120168469A (cg-RX-API-DMAC7.html)
AU (2) AU2021276912B2 (cg-RX-API-DMAC7.html)
CA (1) CA3180829A1 (cg-RX-API-DMAC7.html)
IL (1) IL297975A (cg-RX-API-DMAC7.html)
TW (2) TWI858258B (cg-RX-API-DMAC7.html)
WO (1) WO2021234544A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20251596T1 (hr) 2017-08-31 2026-01-30 Novartis Ag Nove upotrebe derivata piperidinil-indola
CN120168469A (zh) * 2020-05-18 2025-06-20 诺华股份有限公司 Lnp023的结晶形式
US11951101B2 (en) 2020-07-16 2024-04-09 Novartis Ag Methods of using factor B inhibitors
US20240109861A1 (en) * 2020-12-30 2024-04-04 Medshine Discovery Inc. Series of piperidine-substituted benzoic acid compounds, and use thereof
WO2022234541A1 (en) * 2021-05-07 2022-11-10 Novartis Ag Iptacopan for the treatment of atypical hemolytic uremic syndrome
US20240277689A1 (en) 2021-06-18 2024-08-22 Novartis Ag Method of treating an autoimmune hematological disorder
WO2023166487A1 (en) 2022-03-04 2023-09-07 Novartis Ag Use of iptacopan for the treatment of lupus nephritis
KR20250027806A (ko) * 2022-06-30 2025-02-27 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 질소 함유 브릿지 헤테로시클릭 유도체의 약학적으로 허용 가능한 염, 결정형 및 이의 제조 방법
AU2024226444A1 (en) 2023-02-23 2025-07-24 Novartis Ag Methods of using factor b inhibitors
TW202508580A (zh) 2023-08-25 2025-03-01 瑞士商諾華公司 使用因子b抑制劑之方法
AU2024417894A1 (en) * 2024-01-10 2026-07-30 Hebei Yiling Medicine Research Institute Co. Ltd. Piperidinyl indole derivative, preparation method therefor and use thereof
WO2025172910A1 (en) 2024-02-16 2025-08-21 Novartis Ag Factor b inhibitors for treatment of anca-associated vasculitis
WO2026003809A1 (en) 2024-06-29 2026-01-02 Assia Chemical Industries Ltd. Solid state forms of iptacopan hydrochloride
WO2026093943A1 (en) 2024-10-31 2026-05-07 Novartis Ag Chemical process for preparing phenylpiperidinyl indole derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds
WO2011153221A1 (en) 2010-06-01 2011-12-08 Plus Chemicals Sa Solid state forms of ixabepilone
JO3425B1 (ar) * 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
LT3394089T (lt) 2015-12-23 2021-11-25 eleva GmbH Polipeptidai, skirti komplemento aktyvacijos inhibicijai
HRP20251596T1 (hr) 2017-08-31 2026-01-30 Novartis Ag Nove upotrebe derivata piperidinil-indola
CN120168469A (zh) * 2020-05-18 2025-06-20 诺华股份有限公司 Lnp023的结晶形式

Similar Documents

Publication Publication Date Title
JP2024036694A5 (cg-RX-API-DMAC7.html)
JP2024032941A5 (cg-RX-API-DMAC7.html)
JP2025041734A5 (cg-RX-API-DMAC7.html)
JP2025069142A5 (cg-RX-API-DMAC7.html)
JP2023526975A5 (cg-RX-API-DMAC7.html)
JP2022122972A5 (cg-RX-API-DMAC7.html)
JP2024116190A5 (cg-RX-API-DMAC7.html)
JP2024114921A5 (cg-RX-API-DMAC7.html)
JP2022185040A5 (cg-RX-API-DMAC7.html)
JP2024026077A5 (cg-RX-API-DMAC7.html)
JP2024161376A5 (cg-RX-API-DMAC7.html)
JP2025176106A5 (cg-RX-API-DMAC7.html)
JP2023182571A5 (cg-RX-API-DMAC7.html)
JP2023133317A5 (cg-RX-API-DMAC7.html)
JP2023116477A5 (cg-RX-API-DMAC7.html)
JP2025148617A5 (cg-RX-API-DMAC7.html)
JP2025098156A5 (cg-RX-API-DMAC7.html)
JP2022064180A5 (cg-RX-API-DMAC7.html)
JP2020079331A5 (cg-RX-API-DMAC7.html)
JP2024149687A5 (cg-RX-API-DMAC7.html)
JP2024099585A5 (cg-RX-API-DMAC7.html)
JP2022518056A5 (cg-RX-API-DMAC7.html)
JP2023012502A5 (cg-RX-API-DMAC7.html)
JP2025090801A5 (cg-RX-API-DMAC7.html)
JP2025094038A5 (cg-RX-API-DMAC7.html)